Studies in breast cancer have suggested a link to EMT through induction of Cripto-1 and the c-Src pathway [16], although this is contradicted by studies showing that Msx2 downregulates the prometastatic factor BSP [18]. This evidence concerns the gene MSX2 and breast cancer.